{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:09:35Z","timestamp":1791940175284,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T00:00:00Z","timestamp":1473120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1208\/s12248-016-9973-3","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T16:33:37Z","timestamp":1473179617000},"page":"1524-1531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study"],"prefix":"10.1208","volume":"18","author":[{"given":"Heli","family":"Savolainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Meerlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip H.","family":"Elsinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi A.J.O.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola A.","family":"Colabufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aren","family":"van Waarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Luurtsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"issue":"2, 3","key":"9973_CR1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","volume":"36","author":"AH Schinkel","year":"1999","unstructured":"Schinkel AH. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev. 1999;36(2, 3):179\u201394.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"9973_CR2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/jpet.107.130294","volume":"325","author":"X Liu","year":"2008","unstructured":"Liu X, Chen C, Smith BJ. Progress in brain penetration evaluation in drug discovery and development. J Pharmacol Exp Ther. 2008;325(2):349\u201356.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9973_CR3","first-page":"268","volume":"3","author":"M Sukhai","year":"2000","unstructured":"Sukhai M, Piquette-Miller M. Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci. 2000;3(2):268\u201380.","journal-title":"J Pharm Pharm Sci"},{"key":"9973_CR4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/pr.107.07109","volume":"60","author":"DS Miller","year":"2008","unstructured":"Miller DS, Bauer B, Hartz AMS. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev. 2008;60:196\u2013209.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"9973_CR5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/jnc.12344","volume":"127","author":"GNY Chan","year":"2013","unstructured":"Chan GNY, Saldivia V, Yang Y, Pang H, de Lannoy I, Bendayan R. In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study. J Neurochem. 2013;127(3):342\u201352.","journal-title":"J Neurochem"},{"issue":"1, 2","key":"9973_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2010.12.013","volume":"94","author":"L Moerman","year":"2011","unstructured":"Moerman L, Wyffels L, Slaets D, Raedt R, Boon P, De Vos F. Antiepileptic drugs modulate P-glycoproteins in the brain: a mice study with 11C-desmethylloperamide. Epilepsy Res. 2011;94(1, 2):18\u201325.","journal-title":"Epilepsy Res"},{"issue":"4","key":"9973_CR7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1471-4159.2012.07890.x","volume":"123","author":"S Yousif","year":"2012","unstructured":"Yousif S, Chaves C, Potin S, Margaill I, Scherrmann J-M, Decl\u00e8ves X. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA\/COX-2 activation. J Neurochem. 2012;123(4):491\u2013503.","journal-title":"J Neurochem"},{"issue":"1","key":"9973_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.meegid.2009.09.018","volume":"10","author":"RL Benish","year":"2010","unstructured":"Benish RL, Rodriguez B, Zimmerman PA, Mehlotra RK. Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations. Infect Genet Evol. 2010;10(1):60\u20137.","journal-title":"Infect Genet Evol"},{"issue":"1","key":"9973_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2005.11.009","volume":"27","author":"P Breedveld","year":"2006","unstructured":"Breedveld P, Beijnen JH, Schellens JHM. Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol Sci. 2006;27(1):17\u201324.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"9973_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.104.001230","volume":"33","author":"A Doran","year":"2005","unstructured":"Doran A, Obach RS, Smith BJ, Hosea NA, Becker S, Callegari E, et al. The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the mdr1a\/1b knockout mouse model. Drug Metab Dispos. 2005;33(1):165\u201374.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"9973_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1476-5381.2011.01557.x","volume":"165","author":"FE O\u2019Brien","year":"2012","unstructured":"O\u2019Brien FE, Dinan TG, Griffin BT, Cryan JF. Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings. Br J Pharmacol. 2012;165(2):289\u2013312.","journal-title":"Br J Pharmacol"},{"issue":"8","key":"9973_CR12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrn1177","volume":"4","author":"MH Hastings","year":"2003","unstructured":"Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4(8):649\u201361.","journal-title":"Nat Rev Neurosci"},{"key":"9973_CR13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brainresrev.2005.01.005","volume":"49","author":"RE Mistlberger","year":"2005","unstructured":"Mistlberger RE. Circadian regulation of sleep in mammals: role of the suprachiasmatic nucleus. Brain Res Brain Res Rev. 2005;49:429\u201354.","journal-title":"Brain Res Brain Res Rev"},{"issue":"2, 3","key":"9973_CR14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.physbeh.2006.09.010","volume":"90","author":"DGM Beersma","year":"2007","unstructured":"Beersma DGM, Gordijn MCM. Circadian control of the sleep-wake cycle. Physiol Behav. 2007;90(2, 3):190\u20135.","journal-title":"Physiol Behav"},{"issue":"4","key":"9973_CR15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/clpt.2010.160","volume":"88","author":"S Ohtsuki","year":"2010","unstructured":"Ohtsuki S, Ito S, Terasaki T. Is P-glycoprotein involved in amyloid-\u03b2 elimination across the blood-brain barrier in Alzheimer\u2019s disease? Clin Pharmacol Ther. 2010;88(4):443\u20135.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"9973_CR16","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-\u03b2 deposition in an Alzheimer disease mouse model. J Clin Invest. 2005;115(11):3285\u201390.","journal-title":"J Clin Invest"},{"issue":"1","key":"9973_CR17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.arr.2013.10.001","volume":"13","author":"MA Castello","year":"2014","unstructured":"Castello MA, Soriano S. On the origin of Alzheimer\u2019s disease. Trials and tribulations of the amyloid hypothesis. Ageing Res Rev. 2014;13(1):10\u20132.","journal-title":"Ageing Res Rev"},{"issue":"12","key":"9973_CR18","first-page":"1537","volume":"70","author":"M Bilgel","year":"2013","unstructured":"Bilgel M, Zhou Y, Wong DF, Ferrucci L, Resnick SM. Self-reported sleep and \u03b2-amyloid deposition in community-dwelling older adults. JAMA Neurol. 2013;70(12):1537\u201343.","journal-title":"JAMA Neurol"},{"issue":"6156","key":"9973_CR19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373\u20137.","journal-title":"Science"},{"issue":"5955","key":"9973_CR20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"J Kang","year":"2009","unstructured":"Kang J, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. Amyloid-\u03b2 dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005\u20137.","journal-title":"Science"},{"issue":"7","key":"9973_CR21","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1021\/mp5008103","volume":"12","author":"H Savolainen","year":"2015","unstructured":"Savolainen H, Cantore M, Colabufo NA, Elsinga PH, Windhorst AD, Luurtsema G. Synthesis and preclinical evaluation of three novel fluorine-18 labeled radiopharmaceuticals for P-glycoprotein PET imaging at the blood-brain barrier. Mol Pharm. 2015;12(7):2265\u201375.","journal-title":"Mol Pharm"},{"key":"9973_CR22","doi-asserted-by":"publisher","unstructured":"Savolainen H, Windhorst AD, Elsinga PH, Cantore M, Colabufo NA, Willemsen ATM, et al. Evaluation of [18F]MC225 as a PET radiotracer for measuring P-glycoprotein function at the blood-brain barrier in rats; kinetics, metabolism, and selectivity. J Cereb Blood Flow Metab. 2016. doi: 10.1177\/0271678X16654493","DOI":"10.1177\/0271678X16654493"},{"issue":"5","key":"9973_CR23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.0007-1331.2002.00790.x","volume":"14","author":"P Meerlo","year":"2002","unstructured":"Meerlo P, Koehl M, van der Borght K, Turek FW. Sleep restriction alters the hypothalamic-pituitary-adrenal response to stress. J Neuroendochrinology. 2002;14(5):397\u2013402.","journal-title":"J Neuroendochrinology"},{"issue":"11","key":"9973_CR24","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/sleep\/31.11.1579","volume":"31","author":"A Novati","year":"2008","unstructured":"Novati A, Roman V, Cetin T, Hagewoud R, den Boer JA, Luiten PG, et al. Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep. 2008;31(11):1579\u201385.","journal-title":"Sleep"},{"issue":"4","key":"9973_CR25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"AH Schinkel","year":"1994","unstructured":"Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994;77(4):491\u2013502.","journal-title":"Cell"},{"issue":"1","key":"9973_CR26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0013-4694(86)90044-1","volume":"64","author":"I Tobler","year":"1986","unstructured":"Tobler I, Borbely AA. Sleep EEG in the rats as a function of prior waking. Electroencephalogr Clin Neurophysiol. 1986;64(1):74\u20136.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"4","key":"9973_CR27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/07420520500180231","volume":"22","author":"H Ando","year":"2005","unstructured":"Ando H, Yanagihara H, Sugimoto K, Hayashi Y, Tsuruoka S, Takamura T, et al. Daily rhythms of P-Glycoprotein expression in mice. Chronobiol Int. 2005;22(4):655\u201365.","journal-title":"Chronobiol Int"},{"issue":"1","key":"9973_CR28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/dmd.108.024174","volume":"37","author":"YK Zhang","year":"2008","unstructured":"Zhang YK, Yeager RL, Klaassen CD. Circadian expression profiles of drug processing genes and transcription factors in mouse liver. Drug Metab Dispos. 2008;37(1):106\u201315.","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"9973_CR29","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2008.07.073","volume":"135","author":"Y Murakami","year":"2008","unstructured":"Murakami Y, Higashi Y, Matsunaga N, Koyanagi S, Ohdo S. Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice. Gastroenterology. 2008;135(5):1636\u201344.","journal-title":"Gastroenterology"},{"issue":"4","key":"9973_CR30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/07420528.2012.668996","volume":"29","author":"A Okyar","year":"2012","unstructured":"Okyar A, Dressler C, Hanafy A, Baktir G, Lemmer B, Spahn-Langguth H. Circadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance. Chronobiol Int. 2012;29(4):443\u201353.","journal-title":"Chronobiol Int"},{"issue":"1","key":"9973_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1124\/mol.114.096735","volume":"88","author":"M Iwasaki","year":"2015","unstructured":"Iwasaki M, Koyanagi S, Suzuki N, Katamune C, Matsunaga N, Watanabe N, et al. Circadian modulation in the intestinal absorption of P-glycoprotein substrates in monkeys. Mol Pharmacol. 2015;88(1):29\u201337.","journal-title":"Mol Pharmacol"},{"issue":"5","key":"9973_CR32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1208\/s12248-014-9625-4","volume":"16","author":"L Kervezee","year":"2014","unstructured":"Kervezee L, Hartman R, van den Berg D-J, Shimizu S, Emoto-Yamamoto Y, Meijer JH, et al. Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain. AAPS J. 2014;16(5):1029\u201337.","journal-title":"AAPS J"},{"issue":"3","key":"9973_CR33","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/jpet.109.162321","volume":"333","author":"H Kodaira","year":"2010","unstructured":"Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y. Kinetic analysis of the cooperation of P-glycoprotein (P-gp\/Abcb1) and breast cancer resistance protein (Bcrp\/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone. J Pharmacol Exp Ther. 2010;333(3):788\u201396.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9973_CR34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.jcbfm.9600349","volume":"27","author":"M Lubberink","year":"2007","unstructured":"Lubberink M, Luurtsema G, van Berckel BNM, Boellaard R, Toornvliet R, Windhorst AD, et al. Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C]verapamil and PET. J Cereb Blood Flow Metab. 2007;27(2):424\u201333.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"9973_CR35","doi-asserted-by":"crossref","first-page":"H1662","DOI":"10.1152\/ajpheart.01242.2004","volume":"289","author":"CA Wauschkuhn","year":"2005","unstructured":"Wauschkuhn CA, Witte K, Gorbey S, Lemmer B, Schilling L. Circadian periodicity of cerebral blood flow revealed by laser-Doppler flowmetry in awake rats: relation to blood pressure and activity. Am J Physiol Hear Circ Physiol. 2005;289(4):H1662\u20138.","journal-title":"Am J Physiol Hear Circ Physiol"},{"issue":"10","key":"9973_CR36","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/01.STR.21.10.1464","volume":"21","author":"Y Endo","year":"1990","unstructured":"Endo Y, Jinnai K, Endo M, Fujita K, Kimura F. Diurnal variation of cerebral blood flow in rat hippocampus. Stroke. 1990;21(10):1464\u20139.","journal-title":"Stroke"},{"key":"9973_CR37","first-page":"109","volume":"4","author":"TA Glauser","year":"2014","unstructured":"Glauser TA, Pippenger CE. Chronotherapy in the treatment of epilepsy. ChronoPhysiology Ther. 2014;4:109\u201323.","journal-title":"ChronoPhysiology Ther"},{"issue":"9, 10","key":"9973_CR38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.addr.2010.04.011","volume":"62","author":"N Takeda","year":"2010","unstructured":"Takeda N, Maemura K. Cardiovascular disease, chronopharmacotherapy, and the molecular clock. Adv Drug Deliv Rev. 2010;62(9, 10):956\u201366.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"9973_CR39","first-page":"56","volume":"6","author":"V Singh","year":"2014","unstructured":"Singh V, Deshpande A. The emergence of time programmed drug delivery system: chronotherapy of cardio vascular diseases. Int J Pharm Pharm Sci. 2014;6(10):56\u201360.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"4","key":"9973_CR40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/07853890.2014.920213","volume":"46","author":"R Kondratov","year":"2014","unstructured":"Kondratov R. Circadian clock and cancer therapy: an unexpected journey. Ann Med. 2014;46(4):189\u201390.","journal-title":"Ann Med"},{"issue":"5","key":"9973_CR41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nrc1072","volume":"3","author":"L Fu","year":"2003","unstructured":"Fu L, Lee CC. The circadian clock: pacemaker and tumor suppressor. Nat Rev. 2003;3(5):350\u201361.","journal-title":"Nat Rev"},{"key":"9973_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-642-25950-0_11","volume":"217","author":"E Ortiz-Tudela","year":"2013","unstructured":"Ortiz-Tudela E, Mteyrek A, Ballesta A, Innominato PF, Levi F. Cancer chronotherapeutics: experimental, theoretical, and clinical aspects. Circadian Clocks. 2013;217:261\u201388.","journal-title":"Circadian Clocks"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-016-9973-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-016-9973-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-016-9973-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:06:19Z","timestamp":1498327579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-016-9973-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["9973"],"URL":"https:\/\/doi.org\/10.1208\/s12248-016-9973-3","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}